Inborn Errors of Carbohydrate Metabolism

  • Robert Schwartz


Many disorders of carbohydrate metabolism have an inherited, molecular basis,1 but do not necessarily present in the perinatal period. This chapter discusses disorders that involve monosaccharide metabolism, intermediary metabolism, and glycogen metabolism, and is modified from a prior detailed evaluation.1 Most disorders are clinically apparent by late infancy.2


Blood Glucose Concentration Inborn Error Glycogen Storage Disease Glycogen Storage Disease Type Hereditary Fructose Intolerance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cornblath M, Schwartz R. Disorders of carbohydrate metabolism in infancy. Boston: Blackwell Scientific, 1991: 7–10.Google Scholar
  2. 2.
    Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular basis of inherited disease. 7th ed. New York: McGraw-Hill, 1995:Chapters 23–25.Google Scholar
  3. 3.
    Von Reuss A. Zuckerausscheidung im Saughlingsalter. Wien Med Wochenschr 1908; 58: 799–803.Google Scholar
  4. 4.
    Goppert F. Galacktosurie nach milchzuckergabe bei angelborenum, familiarem, chronischem leberleiden. Berl Klin Wochenschr 1917; 54: 473–477.Google Scholar
  5. 5.
    Mason HH, Turner ME. Chronic galactemia: report of case with studies on carbohydrates. Am J Dis Child 1935; 50: 359–374.Google Scholar
  6. 6.
    Goldbloom A, Brickman HF. Galactemia. J Pediatr 1946; 28: 674–691.PubMedCrossRefGoogle Scholar
  7. 7.
    Donnell GN, Lann SH. Galactosemia. Pediatrics 1951; 7: 503–514.Google Scholar
  8. 8.
    Komrower GM, Schwarz V, Holzel A, Goldberg L. A clinical and biochemical study of galactosemia. Arch Dis Child 1956; 31: 254–264.PubMedCrossRefGoogle Scholar
  9. 9.
    Hsia DY-Y, Walker FA. Variability in the clinical manifestations of galactosemia. J Pediatr 1961; 59: 87 2883.Google Scholar
  10. 10.
    Hsia DY-Y. Clinical variants of galactosemia. Metabolism 1967; 16: 419–437.PubMedCrossRefGoogle Scholar
  11. 11.
    Nadler HL, Inouye T, Hsia DY-Y. Classical galactosemia: a study of fifty-five cases. In: Hsia DY-Y, ed. Galactosemia. Springfield, IL: Charles C. Thomas, 1969: 127–139.Google Scholar
  12. 12.
    Greenberg CR, Dilling LA, Thompson R, et al. Newborn screening for galactosemia: a new method used in Manitoba. Pediatrics 1989; 84: 331–335.PubMedGoogle Scholar
  13. 13.
    Segal S, Berry GT. Disorders of galactose metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. 7th ed. New York: McGraw-Hill, 1995: 967–1000.Google Scholar
  14. 14.
    Townsend EH Jr, Mason HH, Strong PS. Galactosemia and its relation to Laennec’s cirrhosis; review of literature and presentation of 6 additional cases. Pediatrics 1951; 7: 760–773.PubMedGoogle Scholar
  15. 15.
    Fanconi G. Hochgradige galaktose intolerance (galaktose diabetes) bei einem kunde mit neurofibromatosis recklinghausen. Jahrbuch Kinderheilkunde 1933; 138: 1–8.Google Scholar
  16. 16.
    Beutler E, Blunda MC, Sturgeon P, Day RW. The genetics of galactose-1-phosphate uridyl transferase deficiency. J Lab Clin Med 1966; 64: 646–658.Google Scholar
  17. 17.
    Mellman WJ, Tedesco TA, Baker L. A new genetic abnormality. Lancet 1965; 1: 1395–1396.CrossRefGoogle Scholar
  18. 18..
    Gitzelmann R. Deficiency of erythrocyte galactokinase in a patient with galactose diabetes. Lancet 1965; 2: 670–671.PubMedCrossRefGoogle Scholar
  19. 19.
    Cuatrecasas P, Segal S. Galactose conversion to D-xylose: an alternate route of galactose metabolism. Science 1966; 153: 549–551.PubMedCrossRefGoogle Scholar
  20. 20.
    Gitzelmann R. Hereditary galactokinase deficiency; a newly recognized cause of juvenile cataracts. Pediatr Res 1967; 1: 14–23.CrossRefGoogle Scholar
  21. 21.
    Leloir LF. The metabolism of hexosephosphates. In: McElroy WD, Glass B, eds. Symposium on phosphorus metabolism, vol. 1. Baltimore: Johns Hopkins University Press, 1951: 67–116.Google Scholar
  22. 22.
    Leloir LF. Enzymatic transformation of uridine diphosphate glucose into a galactose derivative. Arch Biochem Biophysics 1951; 33: 186–190.CrossRefGoogle Scholar
  23. 23.
    Eisenberg FJR, Isselbacher KJ, Kalckar HM. Studies on metabolism of carbon-14-labelled galactose in a galactosemic individual. Science 1957; 125: 116–117.PubMedCrossRefGoogle Scholar
  24. 24.
    Segal S, Blair A, Topper YJ. Oxidation of carbon14-labelled galactose by subjects with congenital galactosemia. Science 1962; 136: 150–151.PubMedCrossRefGoogle Scholar
  25. 25.
    Ng WG, Bergren WR, Donnell GN. Galactose-1phosphate uridyl transferase activity in galactosemia. Nature 1964; 203: 845–847.CrossRefGoogle Scholar
  26. 26.
    Isselbacher KJ. Evidence for an accessory pathway of galactose metabolism in mammalian liver. Science 1957; 125: 652–654.CrossRefGoogle Scholar
  27. 27.
    Gitzelmann R, Curtis HC, Muller M. Galactitol excretion in the urine of a galactokinase-deficient man. Biochem Biophys Res Commun 1966; 22: 437–441.CrossRefGoogle Scholar
  28. 28.
    Gitzelmann R, Steinman B, eds. Galactosemia symposium. Eur J Pediatr 1995;154(suppl):S1–S106.Google Scholar
  29. 29.
    Ellis C, Wilcox AR, Goldberg DM. Experience of routine live-birth screening for galactosemia in a British hospital with emphasis on heterozygote detection. Arch Dis Child 1972; 47: 34–40.PubMedCrossRefGoogle Scholar
  30. 30.
    Levy HL, Sepe SJ, Shih VE, et al. Sepsis due to Escherichia coli in neonates with galactosemia. N Engl J Med 1977; 297: 823–825.PubMedCrossRefGoogle Scholar
  31. 31.
    Pesce MA, Bodourian SH. Clinical significance of plasma galactose and erythrocyte galactose-1-phosphate measurements in transferase-deficient galactosemia and in individuals with below-normal transferase activity. Clin Chem 1982; 28 (2): 301–305.PubMedGoogle Scholar
  32. 32.
    Borden M. Screening for metabolic disease. In: Nyhan WL, ed. Abnormalities in amino acid metabolism in clinical medicine. Norwalk, CT: Appleton-Century, 1984:401418.Google Scholar
  33. 33.
    Gitzelman R. Newborn screening for inherited disorders of galactose metabolism. In: Bickel H, Guthrie R, Hammersen G, eds. Neonatal screening for inborn errors of metabolism. Berlin: Springer-Verlag, 1980: 67–79.CrossRefGoogle Scholar
  34. 34.
    Paigen K, Pacholec F, Levy HL. A new method of screening for inherited disorders of galactose metabolism. J Lab Clin Med 1982; 99: 895–907.PubMedGoogle Scholar
  35. 35.
    Bowling FG, Brown ARD. Development of a protocol for newborn screening for disorders of the galactose metabolic pathway. J Inherited Metab Dis 1986; 9: 99–104.PubMedCrossRefGoogle Scholar
  36. 36.
    Ng WG, Kawamura M, Donnell GN. Galactosemia screening: methodology and outcome from worldwide data collection. In: Therrell BL Jr, ed. Advances in neonatal screening. New York: Elsevier Science, 1987; 243–249.Google Scholar
  37. 37.
    Schweitzer S. Newborn mass screening for galactosemia. Eur J Pediatr 1995; 154 (suppl 2): S37–S39.PubMedCrossRefGoogle Scholar
  38. 38.
    Ritter JA, Cannon EJ. Galactosemia with cataracts; report of a case with notes on physiopathology. N Engl J Med 1955; 252: 747–752.PubMedCrossRefGoogle Scholar
  39. 39.
    Roe TF, Hallatt JG, Donnell GN, Ng WG. Childbearing by a galactosemic woman. J Pediatr 1971; 78: 1026–1030.PubMedCrossRefGoogle Scholar
  40. 40.
    Holzel A. Some aspects of galactosemia. Mod Probl Paediatr 1959; 4: 388 (Biblio-Paediatrica, fasc. 70).Google Scholar
  41. 41.
    Donnell GN, Collado M, Koch R. Growth and development of children with galactosemia. J Pediatr 1961; 58: 836–844.PubMedCrossRefGoogle Scholar
  42. 42.
    Nelson D. Verbal dyspraxia in children with galactosemia. Eur J Pediatr 1995; 154 (suppl 2): S6–S7.PubMedCrossRefGoogle Scholar
  43. 43.
    Hugh-Jones K, Newcomb AL, Hsia DY-Y. The genetic mechanism of galactosemia. Arch Dis Child 1960; 35: 52 1528.Google Scholar
  44. 44.
    Mortensen O, Sondergaard G. Galactosemia (progress in pediatrics). Acta Paediatr 1954; 43: 467–477.PubMedCrossRefGoogle Scholar
  45. 45.
    Isselbacher KJ. Galactosemia. In: Stanbury JB, Wyngaarden JB, Frederickson DS, eds. The metabolic basis of inherited diseases. New York: McGraw-Hill, 1960; 208–225.Google Scholar
  46. 46.
    Borden M. Screening for metabolic disease in abnormalities. In: Nyhan WL, ed. Amino acid metabolism in clinical medicine. Norwalk: Appleton-Century, 1984; 401–418.Google Scholar
  47. 47.
    Dahlqvist A, Svenningsen NW. Galactose in the urine of newborn infants. J Pediatr 1969; 75: 454–462.PubMedCrossRefGoogle Scholar
  48. 48.
    Kirkman HN. Galactosemia. Symposium on hereditary metabolic disease. Metabolism 1960; 9: 316–325.PubMedGoogle Scholar
  49. 49.
    Hsia DY-Y. Galactosemia: Biohemical methods. Charles C. Thomas, Publ. Springfield, IL. 1969: 37–126.Google Scholar
  50. 50.
    Shin YS, Rieth WE, Schaub J. Prenatal diagnosis of galactosemia and properties of galactose-1-phosphate uridyl transferase in erythrocytes of galactosemic variants as well as in human fetal and adult organs. Clin Chim Acta 1983; 128: 271–281.PubMedCrossRefGoogle Scholar
  51. 51.
    Rolland MO, Mandou G, Farriaux JP, Dorche C. Galactose-1-phosphate uridyl transferase activity in chorionic villus: a first trimester prenatal diagnosis of galactosemia. J Inherited Metab Dis 1986; 9: 284–286.CrossRefGoogle Scholar
  52. 52.
    Holton B. Effects of galactosemia in utero. Eur J Pediatr 1995; 154 (suppl 2): S77–S81.PubMedCrossRefGoogle Scholar
  53. 53.
    Allen JT, Gillett M, Holton JB, et al. Evidence of galactosemia in utero. Lancet 1980; 1: 603.PubMedCrossRefGoogle Scholar
  54. 54.
    Jakobs C, Warner TG, Sweetman L, Nyhan WL. Stable isotope dilution analysis of galactitol in amniotic fluid: an accurate approach to the prenatal diagnosis of galactosemia. Pediatr Res 1984; 18 (4): 714–718.PubMedCrossRefGoogle Scholar
  55. 55.
    Shin-Buehring YS, Beier T, Tan A, et al. The activity of galactose-1-phosphate uridyl transferase and galactokinase in human fetal organs. Pediatr Res 1977; 11: 1045 1051.Google Scholar
  56. 56.
    Dahlqvist A. Test paper for galactose in urine. Scand J Clin Lab Invest 1966;18(suppl 92):101; 1968: 22: 87–93.CrossRefGoogle Scholar
  57. 57.
    Cornblath M, Schwartz R. Disorders of carbohydrate metabolism in infancy. 3rd ed. Cambridge. MA: Blackwell Scientific, 1991: 389–403.Google Scholar
  58. 58.
    Kelly S. Septicemia in galactosemia. JAMA 1971; 216: 330.PubMedCrossRefGoogle Scholar
  59. 59.
    Shih VE, Levy HL, Karolkewicz BA, et al. Galactosemia screening of newborns in Massachusetts. N Engl J Med 1971; 284: 753–757.PubMedCrossRefGoogle Scholar
  60. 60.
    Haworth JC, MacDonald MS. Reducing sugars in the urine and blood of premature babies. Arch Dis Child 1957; 32: 417–421.PubMedCrossRefGoogle Scholar
  61. 61.
    Irons M, Levy HL, Pueschel S, Castree K. Accumulation of galactose-1-phosphate in the galactosemic fetus despite maternal milk avoidance. J Pediatr 1985; 107 (2): 261–263.PubMedCrossRefGoogle Scholar
  62. 62.
    Gitzelmann R, Hansen RG. Galactose biogenesis and disposal in galactosemics. Biochim Biophys Acta 1974; 372: 374–378.CrossRefGoogle Scholar
  63. 63.
    Gitzelmann R, Auricchio S. The handling of soya agalactosides by a normal and a galactosemic child. Pediatrics 1965; 36: 231–235.PubMedGoogle Scholar
  64. 64.
    Holzel A, Komrower GM, Schwarz V. Low-lactose milk for congenital galactosaemia (letter to the editor). Lancet 1955; 2: 92.CrossRefGoogle Scholar
  65. 65.
    Koch R, Acosta P, Ragsdale N, Donnell GN. Nutrition in the treatment of galactosemia. J Am Diet Assoc 1963; 43: 216–222.PubMedGoogle Scholar
  66. 66.
    Donnell GN, Bergren WR, Bretthauer RK, Hansen RG. The enzymatic expression of heterozygosity in families of children with galactosemia. Pediatrics 1960; 25: 572–581.PubMedGoogle Scholar
  67. 67.
    Meera Khan P, Robson EB. Report of the committee on the genetic constitution of chromosome 9, Cytogen. Cell Genet 1978; 22: 106–110.CrossRefGoogle Scholar
  68. 68.
    Levy HL, Hammersen G. Newborn screening for galactosemia and other galactose metabolism defects. J Pediatr 1978; 92: 871–877.PubMedCrossRefGoogle Scholar
  69. 69.
    Reichardt JKV, Berg P. Cloning and characterization of a cDNA encoding human galactose-1-phosphate uridyl transferase. Mol Biol Med 1988; 5: 107–122.PubMedGoogle Scholar
  70. 70.
    Reichardt JKV. Galactosemia is caused by missense mutations: molecular studies and implications for therapy Presented at the symposium “Galactosemia: New Fron- tiers in Research,” sponsored by NICHHD and the Children’s Hospital of Los Angeles, April 1989.Google Scholar
  71. 71.
    Reichardt JKV. Genetic basis of galactosemia. Human Mutat 1992; 1: 190–196.CrossRefGoogle Scholar
  72. 72.
    Lai K, Langley SD, Singh RS, et al. A prevalent mutation for galactosemia among black Americans. J Pediatr 1996 128: 89–95.PubMedCrossRefGoogle Scholar
  73. 73.
    Elsas LJ, Langley S, Steele E, et al. Galactosemia: a strat-egy to identify new biochemical phenotypes and molecular genotypes. Am J Hum Genet 1995; 56: 630–639.PubMedGoogle Scholar
  74. 74.
    Podskarbi T, Reichardt J, Shin YS. Studies of DNA in galactose-1-phosphate uridyl transferase deficiency and the Duarte variant in Germany. J Inherited Metab Dis 1994; 17: 179–150.CrossRefGoogle Scholar
  75. 75.
    Medline A, Medline NM. Galactosemia: early structural changes in the liver. Can Med Assoc J 1972; 107: 877–878.PubMedGoogle Scholar
  76. 76.
    Bell LS, Blair WC, Lindsay S, Watson SJ. Lesions of galactose diabetes; pathological observations. Arch Pathol 1950; 49: 393–403.Google Scholar
  77. 77.
    Crome L. A case of galactosaemia with the pathological and neuropathological findings. Arch Dis Child 1962; 37: 415–421.PubMedCrossRefGoogle Scholar
  78. 78.
    Levy HL, Driscoll SG, Porensky RS, Wender DF. Ovarian failure in galactosemia. N Engl J Med 1984; 310: 50.PubMedGoogle Scholar
  79. 79.
    Schwarz V, Goldberg L, Komrower GM, Holzel A. Some disturbances of erythrocyte metabolism in galactosemia. Biochem J 1956; 62: 34–40.PubMedGoogle Scholar
  80. 80.
    Kalckar HM, Anderson EP, Isselbacher KJ. Galacto semia, a congenital defect in a nucleotide transferase: a preliminary report. Proc Natl Acad Sci USA 1956; 42: 49–51PubMedCrossRefGoogle Scholar
  81. 81.
    Isselbacher KJ, Anderson EP, Kurahashi K, Kalckar HM. Congenital galactosemia, a single enzymatic block in galactose metabolism. Science 1956; 123: 635–636.PubMedCrossRefGoogle Scholar
  82. 82.
    Gitzelmann R. Galactose-1-phosphate in the pathophys iology of galactosemia. Eur J Pediatr 1995; 154 (suppl 2): S45–S49.PubMedCrossRefGoogle Scholar
  83. 83.
    Kaufman FR, Ng WG, Xu YK, et al. Treatment of patients (PTS) with classical galactosemia (G) with oral uridine. Pediatr Res 1989; 25 (4): 142A.Google Scholar
  84. 84.
    Mitchell HS. Cataracts in rats fed on galactose. Proc Soc Exp Biol Med 1935; 32: 971–973.Google Scholar
  85. 85.
    Craig JM, Maddock CE. Observations on nature of galac tose toxicity in rats. Arch Pathol 1953; 55: 118–130.Google Scholar
  86. 86.
    Lerman S. The lens in human and experimental galacto semia. NY J Med 1962; 62: 785–803.Google Scholar
  87. 87.
    Lerman S. The lens in congenital galactosemia. Arch Hypergo-Ophthalmol 1959; 61: 88–92.CrossRefGoogle Scholar
  88. 88.
    Kinoshita JH. Selected topics in ophthalmic biochemistry.Arch Ophthalmol 1963; 70: 558–573.PubMedCrossRefGoogle Scholar
  89. 89.
    Shin YS, Reiter K, Urban A, et al. Early manifestations of cataract in a child heterozygous for classical galactosemia and with diabetes mellitus type 1: increased plasma manni tol concentration in cataract patients. J Inherited Metab Dis 1994; 17: 151–153.PubMedCrossRefGoogle Scholar
  90. 90.
    Sidbury JB Jr. The enzymatic lesions in alactosemia. J Clin Invest 1957; 36: 929 (abstract).Google Scholar
  91. 91.
    Cusworth DC, Dent CE, Glynn FW Amino-aciduria in alactosemia. Arch Dis Child 1955; 30: 150–154.PubMedCrossRefGoogle Scholar
  92. 92.
    Hsia DY-Y, Hsia HH, Green S, et al. Amino-aciduria in galactosemia. Am J Dis Child 1954; 88: 458–465.Google Scholar
  93. 93.
    Urbanowski JC, Cohenford MA, Levy HL, et al.Nonenzymatically galactosylated serum albumin in a galactosemic infant. N Engl J Med 1982; 306: 84–86.PubMedCrossRefGoogle Scholar
  94. 94.
    Coradello H, Pollak A, Scheibenveiter S, et al.Nichtenzymatische glykosylierung von hamoglobin und serumprotein bei kindern mit galaktosamie. Wien Klin Wochenschr 1983; 95 (22): 804–809.PubMedGoogle Scholar
  95. 95.
    Segal S. Defective galactosylation in galactosemia: Is low cell UDP galactose an explanation? Eur J Pediatr 1995; 154 (suppl 2): S65–S71PubMedCrossRefGoogle Scholar
  96. 96.
    Berry GT. The role of polyols in the pathophysiology of hypergalactosemia. Eur J Pediatr 1995; 154 (suppl 2): S53–S64PubMedCrossRefGoogle Scholar
  97. 97.
    Komrower GM, Lee DH. Long-term follow-up of galactosemia. Arch Dis Child 1970; 45: 367–373PubMedCrossRefGoogle Scholar
  98. 98.
    Fishler K, Donnell GN, Bergren WR, Koch R. Intellectual and personality development in children with galacto-semia. Pediatrics 1972; 50: 412–419PubMedGoogle Scholar
  99. 99.
    Fishler K, Koch R, Donnell GN, Wenz E. Developmental aspects of galactosemia from infancy to childhood. Clin Pediatr 1980; 19: 38–44CrossRefGoogle Scholar
  100. 100.
    Gitzelmann R, Steinmann B. Galactosemia: How does long-term treatment change the outcome? Enzyme 1984; 32: 37–46.PubMedGoogle Scholar
  101. 101.
    Jan JE, Wilson RA. Unusual late neurological sequelae in galactosemia. Dev Med Child Neurol 1973; 15: 72–74PubMedCrossRefGoogle Scholar
  102. 102.
    Packman S, Lo W, Schmidt K, et al. Neurologic sequelae. in galactosemia. In: Therrell BL Jr, ed. Advances in neonatal screening. New York: Elsevier Science, 1987: 261Google Scholar
  103. 103.
    Friedman JH, Levy HL, Boustany R-M. Late onset of distinct neurologic syndromes in galactosemic siblings.Neurology 1989; 39: 741–742.PubMedCrossRefGoogle Scholar
  104. 104.
    Waisbren SE, Norman TR, Schnell RR, Levy HL. Speech and language deficits in early-treated children with galactosemia. J Pediatr 1983; 102: 75–77.PubMedCrossRefGoogle Scholar
  105. 105.
    Kaufman FR, McBride-Chang C, Manis FR, et al. Cognitive functioning, neurologic status and brain imaging in classical galactosemia. Eur J Pediatr 1995; 154 (suppl 2): S2–S5.PubMedCrossRefGoogle Scholar
  106. 106.
    Tedesco TA, Morrow G III, Mellman WJ. Normal pregnancy and childbirth in a galactosemic woman. J Pediatr 1972; 81: 1159–1161.PubMedCrossRefGoogle Scholar
  107. 107.
    Kaufman FR, Kogut MD, Donnell GN, et al. Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 1981; 304: 994–998.PubMedCrossRefGoogle Scholar
  108. 108.
    Chen YT, Mattison DR, Schulman JD. Hypogonadism and galactosemia. N Engl J Med 1981; 305: 464–465.CrossRefGoogle Scholar
  109. 109.
    Robinson ACR, Dockeray CJ, Cullen MJ, Sweeney EC.Hypergonadotrophic hypogonadism in classical galacto-saemia: evidence for defective oogenesis. Case report. Br J. Obstet Gynaecol 1984; 91: 199–200PubMedCrossRefGoogle Scholar
  110. 110.
    Kaufman FR, Donnell GN, Roe TF, Kogut MD. Gonadal function in patients with galactosaemia. J Inherited Metab Dis 1986; 9: 140–146.PubMedCrossRefGoogle Scholar
  111. 111.
    Fraser IS, Shearman RP, Wilcken B, et al. Failure to identify heterozygotes for galactosaemia in women with premature ovarian failure. Lancet 1987; 2 (8558): 566.PubMedCrossRefGoogle Scholar
  112. 112.
    Kaufman FR, Reichardt JKV, Ng WG, et al. Correlation of cognitive, neurologic and ovarian outcome with the Q188R mutation of the galactose-1-phosphate uridyltransferase gene. J Pediatr 1994; 125: 225–227.PubMedCrossRefGoogle Scholar
  113. 113.
    Beutler E, Baluda MC. An improved method for measuring galactose-1-phosphate uridyl transferase activity of erythrocytes. Clin Chim Acta 1966; 13: 369–379.PubMedCrossRefGoogle Scholar
  114. 114.
    Mathai CK, Beutler E. Electrophoretic variation of galactose-1-phosphate uridyl transferase. Science 1966; 154: 1179–1180.PubMedCrossRefGoogle Scholar
  115. 115.
    Gitzelmann R, Poley JR, Prader A. Partial galactose-1phosphate uridyl transferase deficiency due to a variant enzyme. Helv Paediatr Acta 1967; 22: 252–257.PubMedGoogle Scholar
  116. 116.
    Levy HL, Sepe SJ, Walton DS, et al. Galactose1-phosphate uridyl transferase deficiency due to Duarte/ galactosemia variation: clinical and biochemical studies. J Pediatr 1978; 92: 390–393.PubMedCrossRefGoogle Scholar
  117. 117.
    Kelly S. Significance of the Duarte/classical galactosemic genetic compound. J Pediatr 1979; 92: 937–940.Google Scholar
  118. 118.
    Segal S, Blair A, Roth H. The metabolism of galactose by patients with congenital galactosemia. Am J Med 1965; 38: 62–70.PubMedCrossRefGoogle Scholar
  119. 119.
    Gitzelmann R, Hansen RG. Galactose metabolism, hereditary defects and their clinical significance. In: Burman D, Holton JB, Pennock CA, eds. Inherited disorders of carbohydrate metabolism. Lancaster: MTP Press, 1980: 61–101.CrossRefGoogle Scholar
  120. 120.
    Gitzelmann R. Deficiency of uridine diphosphate galactose 4-epimerase in blood cells of an apparently healthy infant. Helv Paediatr Acta 1972; 27: 125–130.PubMedGoogle Scholar
  121. 121.
    Holton JB, Gillett MG, MacFaul R, Young R. Galactosaemia: a new severe variant due to uridine diphosphate galactose-4-epimerase deficiency. Arch Dis Child 1981; 56: 885–887.PubMedCrossRefGoogle Scholar
  122. 122.
    Brandt NJ, Forland A, Mikkelsen M, et al. Galactosemia locus and the Down’s syndrome chromosome. Lancet 1963; 2: 700–703.PubMedCrossRefGoogle Scholar
  123. 123.
    Dahlqvist A, Hall B, Kallen B. Blood galactose1-phosphate uridyl transferase activity in dysplastic patients with and without chromosomal aberrations. Hum Hered 1969; 19: 628–640.PubMedCrossRefGoogle Scholar
  124. 124.
    Gitzelmann R, Wells HJ, Segal S. Galactose metabolism in a patient with hereditary galactokinase deficiency. Eur J Clin Invest 1974; 4: 79–84.PubMedGoogle Scholar
  125. 125.
    Thalhammer O, Gitzelmann R, Pantlitschko MD. Hypergalactosemia and galactosuria due to galactokinase deficiency in a newborn. Pediatrics 1968; 42: 441–445.PubMedGoogle Scholar
  126. 126.
    Linneweh F, Schaumloffel E, Vetrella M. Galaktokinasedefekt bei einem neugeborenen. Klin Wochenschr 1970; 48: 31–33.PubMedCrossRefGoogle Scholar
  127. 127.
    Dahlqvist A, Gamstorp I, Madsen H. A patient with hereditary galactokinase deficiency. Acta Paediatr Scand 1970; 59: 669–675.PubMedCrossRefGoogle Scholar
  128. 128.
    Cook JGH, Don NA, Mann TP. Hereditary galactokinase deficiency. Arch Dis Child 1971; 46: 465–469.PubMedCrossRefGoogle Scholar
  129. 129.
    Kerr MM. Logan RW, Cant JS, Hutchison JH. Galactokinase deficiency in a newborn infant. Arch Dis Child 1971; 46: 864–866.PubMedCrossRefGoogle Scholar
  130. 130.
    Monteleone JA, Beutler E, Monteleone PL, et al. Cataracts, galactosuria, and hypergalactosemia due to galactokinase deficiency in a child. Am J Med 1971; 50: 403407.Google Scholar
  131. 131.
    Olambiwonnu NO, McVie R, Ng WG, et al. Galactokinase deficiency in identical twins: clinical and biochemical studies. Pediatrics 1974; 53: 314–318.PubMedGoogle Scholar
  132. 132.
    Ng WG, Donnell GN, Bergren WR. Galactokinase activity in human erythrocytes of individuals at different ages. J Lab Clin Med 1965; 66: 115–121.Google Scholar
  133. 133.
    Vigneron C, Marchal C, Deifts C, et al. Deficit partiel et transitoire en galactokinase erythrocytaire chez un nouveau-ne. Arch Fr Pediatr 1970; 27: 523–531.PubMedGoogle Scholar
  134. 134.
    Gitzelmann R, Illig R. Inability of galactose to mobilize insulin in galactokinase-deficient individuals. Diabetologia 1969; 5: 143–145.PubMedCrossRefGoogle Scholar
  135. 135.
    Gitzelmann R. Hereditary galactokinase deficiency. Citation Classics in Current Contents 1987; 25: 14.Google Scholar
  136. 136.
    Mayes JS. Screening for heterozygotes of the galactose enzyme deficiencies. In: Hsia DY-Y, ed. Galactosemia. Springfield, IL: Charles C. Thomas, 1969: 291–296.Google Scholar
  137. 137.
    Shin-Buehring YS, Stuempfig L, Pouget E, et al. Characterization of galactose-1-phosphate uridyl-transferase and galactokinase in human organs from the fetus and adult. Clin Chim Acta 1981; 112: 257–265.PubMedCrossRefGoogle Scholar
  138. 138.
    Beutler E, Matsumoto F, Kuhl W, et al. Galactokinase deficiency as a cause of cataracts. N Engl J Med 1973; 288: 1203–1206.PubMedCrossRefGoogle Scholar
  139. 139.
    Schapira F, Schapira G, Dreyfus JC. La lesion enzymatique de la fructosurie benigne. Enzymol Biol Clin 1962; 1: 170–175.Google Scholar
  140. 140.
    Chambers RA, Pratt YTC. Idiosyncrasy to fructose. Lancet 1956; 2: 340.CrossRefGoogle Scholar
  141. 141.
    Froesch ER, Prader A, Labhart R, et al. Die hereditare Fructoseintoleranz, eine bisher nicht bekannte kongenitale Stoffwechselstorung. Schweiz Med Wochenschr 1957; 87: 1168–1171.PubMedGoogle Scholar
  142. 142.
    Baker L, Winegrad AL. Fasting hypoglycemia and metabolic acidosis associated with deficiency of hepatic fructose-1,6-diphosphatase activity. Lancet 1970; 2: 13–16.PubMedCrossRefGoogle Scholar
  143. 143.
    Perheentupa J, Raivio KO, Nikkila EA. Hereditary fructose intolerance. Acta Med Scand 1972;(suppl)542:65–75.Google Scholar
  144. 144.
    Nikkila EA, Huttunen JK, eds. Clinical and metabolic aspects of fructose (symposium). Acta Med Scand 1972 (suppl)542: 1–244.Google Scholar
  145. 145.
    Froesch ER. Essential fructosuria and hereditary fructose intolerance. In: Stanbury JB, Wyngaarden JB, Fredricks DS, eds. The metabolic basis of inherited disease. 2nd ed. New York: McGraw-Hill, 1966: 124–140.Google Scholar
  146. 146.
    Gitzelmann R, Steinmann B, Van Den Berghe G. Disorders of fructose metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. Metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill, 1995: 905–934.Google Scholar
  147. 147.
    Jeune M, Planson E, Cotte J, et al. L’intolerance 168. hereditaire au fructose. Pediatrie 1961; 16: 605–626.PubMedGoogle Scholar
  148. 148.
    Lelong M, Alagille D, Gentil J, et al. Cirrhose hepatique et tubulopathie par absence congenitale de l’aldolase hepatique. Bull Mem Soc Med Hop Paris 1962; 113: 58–70.Google Scholar
  149. 149.
    Lelong M, Alagille D, Gentil J, et al. L’intolerance hereditaire au fructose. Arch Fr Pediatr 1962; 19: 841–866.PubMedGoogle Scholar
  150. 150.
    Perheentupa J, Pitkanen E, Nikkila EA, et al. Hereditary fructose intolerance. A clinical study of four cases. Ann Paediatr Fenn 1962; 8: 221–235.PubMedGoogle Scholar
  151. 151.
    Cornblath M, Rosenthal IM, Reisner SH, et al. Hereditary fructose intolerance. N Engl J Med 1963; 269: 1271–1278.PubMedCrossRefGoogle Scholar
  152. 152.
    Dubois R, Loeb H, Ooms HA, et al. Etude, d’un cas d’hypoglycemie fonctionelle par intolerance au fructose. Helvet Paediatr Acta 1961; 16: 90–96.Google Scholar
  153. 153.
    Wolfe H, Zschocke E, Wedemeyer FW, Hubner W. Angeborene hereditaire Fructose-intoleranze. Klin Wochenschr 1959; 37: 693–696.CrossRefGoogle Scholar
  154. 154.
    Corsini F. L’intolleranza congenital al fruttosio Clin Pediatr (Bologna) 1960; 42: 716–717.Google Scholar
  155. 155.
    Doherty RA, Williams HE, Field RA. Hereditary fructose intolerance. J Pediatr 1963; 63: 721 (abstract).Google Scholar
  156. 156.
    Lindemann R, Gjessing LR, Merton B, Halvorsen S. Amino acid metabolism in hereditary fructosemia. Acta Paediatr Scand 1970; 59: 141–147.PubMedCrossRefGoogle Scholar
  157. 157.
    Danks DM, Connellan JM, Solomon JR. Hereditary fructose intolerance: report of a case and comments on the hazards of fructose infusion. Aust Paediatr J 1972; 8: 282–286.PubMedGoogle Scholar
  158. 158.
    Kohlin P, Melin D. Hereditary fructose intolerance in four Swedish families. Acta Paediatr Scand 1968; 57: 24–32.PubMedCrossRefGoogle Scholar
  159. 159.
    Baerlocher K, Gitzelmann R, Steinmann B. Clinical and genetic studies of disorders in fructose metabolism. In: Burman D, Holton JB, Pennock CA, eds. Inherited disorders of carbohydrate metabolism. Lancaster: MTP Press, 1980: 163–190.CrossRefGoogle Scholar
  160. 160.
    Steinitz H, Mizrahy O. Essential fructosuria and hereditary fructose intolerance (letter to the editor). N Engl J Med 1969; 280: 222.PubMedGoogle Scholar
  161. 161.
    Gitzelmann R, Baerlocher K. Vorteile und nachteile der fructose in der nahrung. Padiat Forbildiung Praxis 1973; 37: 40–55.Google Scholar
  162. 162.
    Steinman B, Baerlocher K, Gitzelmann R. Hereditare stoerungen des fruktosestoffwechsels: Belastungproben mit Fruktose, Sorbitol und Dihydroxyaceton. Nutr Metab 1975; 18 (suppl 1): 115–132.CrossRefGoogle Scholar
  163. 163.
    Levin B, Snodgrass GJAI, Oberholzer VG, et al. Fructosaemia. Am J Med 1968; 45: 826–838.CrossRefGoogle Scholar
  164. 164.
    Rennert OM, Greer M. Hereditary fructosemia. Neurology 1970; 20: 421–425.PubMedCrossRefGoogle Scholar
  165. 165.
    Cain AAR, Ryman BE. High liver glycogen in hereditary fructose intolerance. Gut 1971; 12: 929–932.PubMedCrossRefGoogle Scholar
  166. 166.
    Morris RCM. An experimental renal acidification defect in patients with hereditary fructose intolerance. II. Its distinction from classic renal tubular acidosis, its resemblance to the renal acidification defect associated with the Fanconi syndrome of children with cystinosis. J Clin Invest 1968; 47: 1648–1663.PubMedCrossRefGoogle Scholar
  167. 167.
    Morris RCJ. Renal tubular acidosis. N Engl J Med 1969;Google Scholar
  168. 168.
    Kranhold JF, Loh D, Morris RCJ. Renal fructose metabo¬lizing enzymes: significance in hereditary fructose intoler¬ance. Science 1969; 165: 402–403.PubMedCrossRefGoogle Scholar
  169. 169.
    Higgins RB, Varney JK. Dissolution of renal calculi in a case of hereditary fructose intolerance and renal tubular acidosis. J Urol 1966; 95: 291–296.PubMedGoogle Scholar
  170. 170.
    Mass RE, Smith WR, Walsh JR. The association of hered¬itary fructose intolerance and renal tubular acidosis. Am J Med Sci 1966; 251: 516–523.PubMedCrossRefGoogle Scholar
  171. 171.
    Penhoet E, Rajkumar R, Rutter WJ. Multiple forms of fructose diphosphate aldolase in mammalian tissue. Proc Natl Acad Sci USA 1966; 56: 1275–1282.PubMedCrossRefGoogle Scholar
  172. 172.
    Hers HG, Joassin G. Anomalie de l’aldolase hepatique dans l’intolerance au fructose. Enzymol Biol Clin 1961; 1: 4–14.Google Scholar
  173. 173.
    Froesch ER, Wolfe HP, Baitsch H, et al. Hereditary fruc¬tose intolerance. An inborn defect of hepatic fructose-1¬phosphate splitting aldolase. Am J Med 1963; 34: 151–167.PubMedCrossRefGoogle Scholar
  174. 174.
    Metais P, Juif J, Sacrez R. Etude biochimique d’un cas d’intolerance hereditaire au fructose. Ann Biol Clin 1962; 20: 801–811.Google Scholar
  175. 175.
    Nikkila EA, Somersalo 0, Pitkanen E, Perheentupa J. Hereditary fructose intolerance, an inborn deficiency of liver aldolase complex. Metabolism 1962; 11: 727–731.Google Scholar
  176. 176.
    Schapira F, Dreyfus JC. L’aldolase hepatique dans l’intolerance au fructose. Rev Fr Etud Clin Biol 1967; 12: 486–489.PubMedGoogle Scholar
  177. 177.
    Schapira F, Nordmann Y, Gregori C. Hereditary alter¬ations of fructose metabolizing enzymes. Acta Med Scand 1972(suppl); 542: 77–83.Google Scholar
  178. 178.
    Nisell J, Linden L. Fructose-1-phosphate aldolase and fructose-1,6-diphosphate aldolase in the mucosa of the intestine in hereditary fructose intolerance. Scand J Gastroenterol 1968; 3: 80–82.PubMedCrossRefGoogle Scholar
  179. 179.
    Morris RCJ, Euki I, Loh D, et al. Absence of renal fruc¬tose-1-phosphate aldolase activity in hereditary fructose intolerance. Nature (London) 1967: 214: 920–921.CrossRefGoogle Scholar
  180. 180.
    Cross NCP, Tolan DR, Cox TM. Catalytic deficiency of human aldolase B in hereditary fructose intolerance caused by a common missense mutation. Cell 1988;53:881–885.Google Scholar
  181. 181.
    Schapira F, Nordmann Y, Dreyfus JC. La lesion biochimique de l’intolerance au fructose. Detection im¬munologique d’une aldolase modifiee. Rev Fr Etud Clin Biol 1968; 13: 267–269.PubMedGoogle Scholar
  182. 182.
    Schapira R, Hatzfeld A, Gregori C. Studies on liver aldo¬lases in hereditary fructose intolerance. Enzyme 1974; 18: 73–83.PubMedGoogle Scholar
  183. 183.
    Gitzelmann R, Steinmann B, Bally C, Lebherz HC. Anti¬body activation of mutant human fructose diphosphate aldolase B in liver extracts of patients with hereditary fructose intolerance. Biochem Biophys Res Commun 1974; 59: 1270–1277.PubMedCrossRefGoogle Scholar
  184. 184.
    Schapira F. Kinetic and immunological abnormalities of aldolase B in hereditary fructose intolerance. Proc Biochem Soc (Abstracts of Communications) 1975; 3: 232.Google Scholar
  185. 185.
    Perheentupa J, Raivio K. Fructose-induced hyperuri¬caemia. Lancet 1967; 2: 528–531.PubMedCrossRefGoogle Scholar
  186. 186.
    Gentil C, Colin J, Valette AM, et al. Etude du 281:1405–1413. metabolisme glucidique au cours de l’intolerance hereditaire au fructose. Essai d’interpretation de l’hypoglucosemie. Rev Fr Etud Clin Biol 1964; 9: 596–607.PubMedGoogle Scholar
  187. 187.
    Endres W, Sierck T, Shin YS. Clinical course of hereditary fructose intolerance in 56 patients. Acta Paediatr Jpn 1988; 30: 452–456.PubMedCrossRefGoogle Scholar
  188. 188.
    Odievre M, Gentil C, Gautier M, Alagille D. Hereditary fructose intolerance in childhood. Am J Dis Child 1978; 132: 605–608.PubMedGoogle Scholar
  189. 189.
    Levin B, Oberholzer VG, Snodgrass GJAI, et al. Fructosaemia, an inborn error of fructose metabolism. Arch Dis Child 1963; 38: 220–230.PubMedCrossRefGoogle Scholar
  190. 190.
    Desbuquois B, Lardinois R, Gentil C, Odievre M. Effets d’une surcharge en phosphate de sodium sur l’hypoglucosemie. Arch Fr Pediatr 1969; 26: 21–35.PubMedGoogle Scholar
  191. 191.
    Grant DB, Allexander FW, Seakins JWT. Abnormal tyrosine metabolism in hereditary fructose intolerance. Acta Paediatr Scand 1970; 59: 432–434.PubMedCrossRefGoogle Scholar
  192. 192.
    Willems C, Heusden A, Renson P, et al. Hypertyrosinemie avec hypermethioninemie neonatale dans un cas d’intolerance au fructose. Helv Paediatr Acta 1971; 26: 467481.Google Scholar
  193. 193.
    Raju L, Chessells JM, Kemball M. Manifestation of hereditary fructose intolerance. Br Med J 1971; 2: 446–447.PubMedCrossRefGoogle Scholar
  194. 194.
    Dominick H-Chr, Hosemann R, Diekmann L. Fructoseintoleranz bei 2 geschwistern. Biochemische und histologische untersuchungen. Monatsschr Kinderheilkd 1972; 120: 32–39.Google Scholar
  195. 195.
    Stampfler G, Heumann G, Schneegans E. Intolerance hereditaire au fructose et anomalies de la crase sanguine. Pediatrie 1972; 27: 169–179.PubMedGoogle Scholar
  196. 196.
    Bagnell P, Hug G, Walling L, Schubert WK. Biochemical and morphological observations in severe infantile fructose intolerance. Pediatr Res 1974; 8: 430 (Abstract).Google Scholar
  197. 197.
    Baerlocher K, Gitzelmann R, Steinmann B, GitzelmannCumarasamy N. Hereditary fructose intolerance in early childhood: a major diagnostic challenge. Helv Paediat Acta 1978; 33: 465–487.PubMedGoogle Scholar
  198. 198.
    Mercier JC, Bourrillon A, Beaufils F, Odievre M. Intolerance hereditaire au fructose a revelation precoce. Arch Franz Pediatr 1976; 33: 945–953.Google Scholar
  199. 199.
    Rossner JA, Feist D. Hereditare fructose intoleranz. Verh Dtsch Ges Pathol 1971; 55: 376–385.PubMedGoogle Scholar
  200. 200.
    Chaptal J, Jean R, Bonnet H, et al. Vomissement acetonemiques symptomatiques d’une intolerance congenitale qu fructose chez deux soeurs. Arch Fr Pediatr 1968; 25: 745–759.PubMedGoogle Scholar
  201. 201.
    Phillips JJ, Little JA, Ptak TW. Subcellular pathology of hereditary fructose intolerance. Am J Med 1968; 44: 910–921.PubMedCrossRefGoogle Scholar
  202. 202.
    Saxon L, Papper S. Abdominal pain occurring during the rapid administration of fructose solutions. N Engl J Med 1957; 256: 132–133.PubMedCrossRefGoogle Scholar
  203. 203.
    Mock DM, Perman JA, Thaler MM, Morris RC Jr. Chronic fructose intoxication after infancy in children with hereditary fructose intolerance. N Engl J Med 1983; 309: 764–770.PubMedCrossRefGoogle Scholar
  204. 204.
    Steinmann B, Gitzelmann R. The diagnosis of hereditary fructose intolerance. Hely Paediat Acta 1981; 36: 297–316.Google Scholar
  205. 205.
    Tolan DR, Penhoet EE. Characterization of the human aldolase B gene. Mol Biol Med 1986; 3: 245–264.PubMedGoogle Scholar
  206. 206.
    Klimmt G, Hubschmann K, Gmyrek D. Untersuchungen zur verminderung des fructosegehalts der Kartoffel. Ein beitrag zur diatetischen behandlung der hereditaren fructoseintoleranz. Monatsschr Kinderheilkd 1968; 116: 21.Google Scholar
  207. 207.
    Perheentupa J, Hallman N. Fructose intolerance. In: Gardner LI, ed. Endocrine and genetic diseases of childhood and adolescence. Philadelphia: WB Saunders, 1969: 844–852.Google Scholar
  208. 208.
    Cross NC, deFranchis R, Sebastio G, et al. Molecular analysis of aldolase B genes in hereditary fructose intolerance. Lancet 1990; 335: 306–309.PubMedCrossRefGoogle Scholar
  209. 209.
    Dazzo C, Tolan DR. Molecular evidence for compound heterozygosity in hereditary fructose intolerance. Am J Hum Genet 1990; 46: 1194–1199.PubMedGoogle Scholar
  210. 210.
    Brooks CC, Buist N, Tuerck J, Tolan DR. Identification of a splice-site mutation in the aldolase B gene from an individual with hereditary fructose intolerance. Am J Hum Genet 1991; 49: 1075–1081.PubMedGoogle Scholar
  211. 211.
    Tolan DR, Brooks CC. Molecular analysis of common aldolase B alleles for hereditary fructose intolerance in North Americans. Biochem Med Metab Biol 1992; 48: 19–25.PubMedCrossRefGoogle Scholar
  212. 212.
    Cross NCP, Cox TM. Hereditary fructose intolerance. Int J Biochem 1990; 22: 685–689.PubMedCrossRefGoogle Scholar
  213. 213.
    Ali M, Rosien U, Cox TM. DNA diagnosis of fatal fructose intolerance from archival tissue. Q J Med 1993; 86: 25–30.PubMedGoogle Scholar
  214. 214.
    Froesch ER, Ginsberg JL. Fructose metabolism of adipose tissue. I. Comparison of fructose and glucose metabolism in epididymal adipose tissue of normal rats. J Biol Chem 1962; 237: 3317–3324.PubMedGoogle Scholar
  215. 215.
    Froesch ER. Fructose metabolism in adipose tissue. Acta Med Scand 1972;(suppl)542:37–46.Google Scholar
  216. 216.
    Park CR, Johnson LH, Wright JH Jr, Batsel H. Effect of insulin on transport of several hexoses and pentoses into cells of muscle and brain. Am J Physiol 1957; 191: 1318.Google Scholar
  217. 217.
    MacGregor S, Singh VN, Davoust S, et al. Evidence for formation of a rabbit liver aldolase-rabbit liver fructose1,6-bisphosphatase complex. Proc Natl Acad Sci USA 1980; 77: 3889–3892.PubMedCrossRefGoogle Scholar
  218. 218.
    Kaletta-Gmunder U, Wolf HP, Leuthardt F. Euber aldolasen. II. Chromatographische Trenning von 1phosphofructaldolase und diphosphofructaldolase der Leber. Helv Chem Acta 1957; 40: 1027–1032.CrossRefGoogle Scholar
  219. 219.
    Peanasky RJ, Lardy HA. Bovine liver aldolase. I. Isolation, crystallization and some general properties. J Biol Chem 1958; 233: 365–370.PubMedGoogle Scholar
  220. 220.
    Munnich A, Besmond C, Darquy S, et al. Dietary and hormonal regulation of aldolase B gene expression. J Clin Invest 1985; 75: 1045–1052.PubMedCrossRefGoogle Scholar
  221. 221.
    Rottman WH, Tolan DR, Penhoet EE. Complete amino acid sequence for human aldolase B derived from cDNA and genomic clones. Proc Natl Acad Sci 1984; 81: 2738 2742.Google Scholar
  222. 222.
    Cox TM, O’Donnell MW, Camilleri M, Burghes AH. Isolation and characterization of a mutant liver aldolase in adult hereditary fructose intolerance. J Clin Invest 1983; 72: 201–213.PubMedCrossRefGoogle Scholar
  223. 223.
    Oberhaensli RD, Taylor DJ, Rajagopalan B, et al. Study of hereditary fructose intolerance by use of 31P magnetic resonance spectroscopy. Lancet 1987; 2: 931–934.PubMedCrossRefGoogle Scholar
  224. 224.
    Gopher A, Vaisman N, Mandel H, Lapidot A. Determination of fructose metabolic pathways in normal and fructose intolerant children: A 13C NMR study using [U13C]fructose. Proc Natl Acad Sci USA 1990; 87: 5449–5453.PubMedCrossRefGoogle Scholar
  225. 225.
    Woods HF, Eggleston LV, Krebs HA. The cause of hepatic accumulation of fructose-1-phosphate on fructose loading. Biochem J 1970; 119: 501–510.PubMedGoogle Scholar
  226. 226.
    Morris RC Jr, McSherry E, Sebastian A. Modulation of experimental renal dysfunction of hereditary fructose intolerance by circulating parathyroid hormone. Proc Natl Acad Sci USA 1971; 68: 132–135.PubMedCrossRefGoogle Scholar
  227. 227.
    Samols E, Dormandy TL. Insulin response to fructose and galactose. Lancet 1963; 1: 478–479.PubMedCrossRefGoogle Scholar
  228. 228.
    Sidbury JB Jr. Zur Biochemie der hereditaren fructoseintoleranz (letter to the editor). Helvet Paediatr Acta 1959; 14: 317–318.Google Scholar
  229. 229.
    Hers H. Augmentation de l’activite de la glucose-6phosphatase dans l’intolerance au fructose. Rev Int Hepatol 1962; 12: 777–782.PubMedGoogle Scholar
  230. 230.
    Thurston JH, Jonas EM, Hauhart RE. Decrease and inhibition of liver glycogen phosphorylase after fructose. Diabetes 1974; 23: 597–604.PubMedGoogle Scholar
  231. 231.
    Kaufmann U, Froesch ER. Inhibition of phosphorylasea by fructose-1-phosphate, d-glycerophosphate and fructose-1,6-diphosphate: explanation for fructose-induced hypoglycemia in hereditary fructose intolerance and fructose-1,6-diphosphatase deficiency. Eur J Clin Invest 1973; 3: 407–413.PubMedCrossRefGoogle Scholar
  232. 232.
    Van Den Berghe G, Hue L, Hers HG. Effect of the administration of fructose on the glycogenolytic action of glucagon. Biochem J 1973; 134: 637–645.Google Scholar
  233. 233.
    Zalitis J, Oliver IT. Inhibition of glucose-phosphate isomerase by metabolic intermediates of fructose. Biochem J 1967; 102: 753–759.PubMedGoogle Scholar
  234. 234.
    Bally C, Leuthardt F. Personal communication.Google Scholar
  235. 235.
    Landau BR, Marshall JS, Craig JW, et al. Quantitation of the pathways of fructose metabolism in normal and fructose-intolerant subjects. J Lab Clin Med 1971; 78: 608–618.PubMedGoogle Scholar
  236. 236.
    Lasker M. Essential fructosuria. Hum Biol 1941; 13: 51–63.Google Scholar
  237. 237.
    Nyhan WL. Inborn errors of biotin metabolism. Arch Dermatol 1987; 123: 1696–1698.PubMedCrossRefGoogle Scholar
  238. 238.
    Saudubray J-M, Marsac C, Charpentier C, et al. Neonatal congenital lactic acidosis with pyruvate carboxylase deficiency in two siblings. Acta Paediatr Scand 1976; 65: 717–724.PubMedGoogle Scholar
  239. 239.
    Hommes FA, Schrijver J, Dias TL. Pyruvate carboxylase deficiency, studies on patients and on an animal model system. In: Burman D, Hallan JB, Pennook CA, eds. Inherited disorders of carbohydrate metabolism. Baltimore: University Park Press, 1979: 269–286.Google Scholar
  240. 240.
    Haworth JC, Robinson BH, Perry TL. Lactic acidosis due to pyruvate carboxylase deficiency. J Inherited Metab Dis 1981; 4: 57–58.PubMedCrossRefGoogle Scholar
  241. 241.
    Robinson BH, Oci J, Sherwood WG, et al. The molecular basis for the two different clinical presentations of classical pyruvate carboxylase deficiency. Am J Hum Genet 1984; 36: 283–294.PubMedGoogle Scholar
  242. 242.
    Fiser RH, Melsher HL, Fischer DA. Hepatic phosphoenolpyruvate carboxykinase deficiency: a new cause of hypoglycemia in childhood. Pediatr Res 1974; 8: 432 (Abstract).Google Scholar
  243. 243.
    Hommes KA, Bendien K, Elema JD, et al. Two cases of phosphoenolpyruvate carboxykinase deficiency. Acta Paediatr Scand 1976; 65: 233–240.PubMedCrossRefGoogle Scholar
  244. 244.
    Vidnes J, Sovik O. Gluconeogenesis in infancy and childhood. II. Studies on the glucose production from alanine in three cases of persistent neonatal hypoglycaemia. Acta Paediatr Scand 1976; 65: 297–305.PubMedCrossRefGoogle Scholar
  245. 245.
    Vidnes J, Sovik O. Gluconeogenesis in infancy and childhood. III. Deficiency of the extramitochondrial form of hepatic phosphoenolpyruvate carboxykinase in a case of persistent neonatal hypoglycaemia. Acta Paediatr Scand 1976; 65: 307–312.PubMedCrossRefGoogle Scholar
  246. 246.
    Lardy HA, Bentle LA, Wagner MJ, et al. Defective phosphoenolpyruvate carboxykinase in victims of sudden infant death syndrome. National Institute of Child Health, Symposium on SIDS, July 1975.Google Scholar
  247. 247.
    Sturner WQ, Susa JB. Sudden infant death and liver phosphoenolpyruvate carboxykinase analysis. Forensic Sci Int 1980; 16: 19–28.PubMedCrossRefGoogle Scholar
  248. 248.
    Baker L, Winegrad AI. Fasting hypoglycemia and metabolic acidosis associated with deficiency of hepatic fructose-1,6-dephosphatase activity. Lancet 1970; 2: 13–16.PubMedCrossRefGoogle Scholar
  249. 249.
    Pagliara AS, Karl EI, Keating JP, et al. Hepatic fructose1,6-diphosphatase deficiency. A cause of lactic acidosis and hypoglycemia in infancy. J Clin Invest 1972; 51: 2115 2123.Google Scholar
  250. 250.
    Baerlocher K, Gitzelmann R, Nussli R, Dumermuth G. Infantile lactic acidosis due to hereditary fructose-1,6diphosphatase deficiency. Helv Paediatr Acta 1971; 26: 489–506.PubMedGoogle Scholar
  251. 251.
    Hulsmann WC, Fernandes J. A child with lactic-acidemia and fructose diphosphatase deficiency in the liver. Pediatr Res 1971; 5: 633–637.CrossRefGoogle Scholar
  252. 252.
    Green HL, Stifel FB, Herman RH. Ketotic hypoglycemia due to hepatic fructose-1,6-diphosphatase deficiency. Treatment with folic acid. Am J Dis Child 1972; 124: 415–418.Google Scholar
  253. 253.
    Melancon SB, Khachadurian AK, Nadler HL, Brown BI. Metabolic and biochemical studies in fructose1,6-diphosphatase deficiency. J Pediatr 1973; 82: 650–657.PubMedCrossRefGoogle Scholar
  254. 254.
    Melancon SB, Nadler HL. Detection of fructose-1,6diphosphatase with use of white blood cells. N Engl J Med 1972; 286: 731–732.PubMedCrossRefGoogle Scholar
  255. 255.
    Saudubray JM, Dreyfus JC, Cepanec C, et al. Acidose lactique, hypoglycemie et hepatomegalie par deficit hereditaire en fructose-1,6-diphosphatase hepatique. Arch Fr Pediatr 1973; 30: 609–632.PubMedGoogle Scholar
  256. 256.
    Retbi JM. Acidose lactique et hypoglycemie par deficit congenital en fructose-1,6-diphosphatase hepatique. Thesis medicine. Paris: Rene Descartes, 1972.Google Scholar
  257. 257.
    Derosas FJ, Wapnir A, Lifshitz F, et al. Folic acid enhanced gluconeogenesis in glycerol-induced hypoglycemia and fructose-1,6-diphosphatase deficiency. The 56th An-nual Meeting of The Endocrine Society, Atlanta, Georgia, June 1974 ( Abstract).Google Scholar
  258. 258.
    Odievre M, Brivet M, Moatti N, et al. Deficit en fructose1,6-diphosphatase ches deux soeurs. Arch Fr Pediatr 1975; 32: 113–121.PubMedGoogle Scholar
  259. 259.
    Hopwood NJ, Holzman I, Drash AL. Fructose-1,6diphosphatase deficiency. Am J Dis Child 1977; 131: 418421.Google Scholar
  260. 260.
    Hommes FA, Campbell R, Steinhart C, et al. Biochemical observations on a case of hepatic fructose1,6-diphosphatase deficiency. J Inherited Metab Dis 1985; 8: 169–173.PubMedCrossRefGoogle Scholar
  261. 261.
    Shin YS. Diagnosis of fructose-1,6-disphosphatase deficiency using leukocytes: normal leukocyte enzyme activity in three female patients. Clin Invest 1993; 71: 115118.Google Scholar
  262. 262.
    Dremsek PA, Sacher M, Stogmann W, et al. Fructose-1,6diphosphatase deficiency: glycerol excretion during fasting test. Eur J Pediatr 1985; 144: 203–204.PubMedCrossRefGoogle Scholar
  263. 263.
    Cahill J, Kirtley ME. FDPase activity in human leukocytes. N Engl J Med 1975; 292: 212–213.PubMedGoogle Scholar
  264. 264.
    Melancon SB, Nadler HL. Letter to the Editor. N Engl J Med 1975; 292: 212–213.Google Scholar
  265. 265.
    Schrijver J, Hommes FA. Activity of fructose-1,6diphosphatase in human leukocytes. N Engl J Med 1975; 292: 1298–1299.PubMedGoogle Scholar
  266. 266.
    Snapper I, Van Creveld S. Un cas d’hypoglycemie avec acetonemie chez un enfant. Bull Mem Soc Med Hop (Paris) 1928; 52: 1315–1324.Google Scholar
  267. 267.
    Von Gierke E. Hepato-nephromegalia glycogenica (Glykogenspeicherkrankheit der leber und nieren). Beitr Pathol 1929; 82: 497–513.Google Scholar
  268. 268.
    Schonheimer R. Uber eine eigenartige storung des kohlehydrat-stoff-wechsels. Hoppe Seylers Z Physiol Chem 1929; 182: 148–150.CrossRefGoogle Scholar
  269. 269.
    Pompe JC. Over idiopatische hypertrophie van het hart. Ned Tijdschr Geneeskd 1932; 76: 304–311.Google Scholar
  270. 270.
    Van Creveld S. Glycogen disease. Medicine 1939; 18: 1128.Google Scholar
  271. 271.
    Van Creveld S. Investigations on glycogen disease. Arch Dis Child 1934; 9: 9–26.PubMedCrossRefGoogle Scholar
  272. 272.
    Mason HH, Andersen DH. Glycogen disease. Am J Dis Child 1941; 61: 795–825.Google Scholar
  273. 273.
    Debre R. Les polyconles. Paris: Gaston Doin, 1947.Google Scholar
  274. 274.
    Andersen DH. Studies on glycogen disease with report of a case in which the glycogen was abnormal. In: Najjar VA, ed. Carbohydrate metabolism. Baltimore: Johns Hopkins University Press, 1952: 28–42.Google Scholar
  275. 275.
    McArdle B. Myopathy due to a defect in muscle glycogen breakdown. Clin Sci 1951; 10: 13–35.Google Scholar
  276. 276.
    Stetten D Jr, Stetten MR. Glycogen metabolism. Physiol Rev 1960; 40: 505–537.PubMedGoogle Scholar
  277. 277.
    Hers H-G, Van Hoof F, de Barsy T. Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. 6th ed. New York: McGraw-Hill, 1989: 425–452.Google Scholar
  278. 278.
    Cori GT. Glycogen structure and enzyme deficiencies in glycogen storage disease. Harvey Lect (1952–53) 1954; 48: 145–171.Google Scholar
  279. 279.
    Hers HG. Glycogen storage disease. In: Levine R, Luft R, eds. Advances in metabolic disorders. vol. 1. New York: Academic Press, 1964: 1–44.Google Scholar
  280. 280.
    Spencer-Peet J, Norman ME, Lake BD, et al. Hepatic glycogen storage disease. Q J Med 1971; 157: 95–114.Google Scholar
  281. 281.
    Moses SW. Pathophysiology and dietary treatment of the glycogen storage diseases. J Pediatr Gastroenterol 1990; 11: 155–174.CrossRefGoogle Scholar
  282. 282.
    Brown DH, Brown BI. Some inborn errors of carbohydrate metabolism. In: Whelan WJ, ed. MTP International review of science, vol. 5. Biochemistry of carbohydrates. London: Butterworth; Baltimore: University Park Press, 1975: 391–426.Google Scholar
  283. 283.
    Cori GT, Cori CF. Glucose-6-phosphatase of the liver in glycogen storage disease. J Biol Chem 1952; 199: 661–667.PubMedGoogle Scholar
  284. 284.
    Hers HG. Glucosidase deficiency in generalized glycogen storage disease (Pompe’s disease) Biochem J 1963; 86: 11.PubMedGoogle Scholar
  285. 285.
    Lewis GM, Spencer-Peet J, Stewart KM. Infantile hypoglycemia due to inherited deficiency of glycogen synthase in liver. Arch Dis Child 1963; 38: 40.PubMedCrossRefGoogle Scholar
  286. 286.
    Van Creveld S. The Blackader lecture, 1962: the clinical course of glycogen disease. Can Med Assoc J 1963; 88: 1–15.PubMedGoogle Scholar
  287. 287.
    Fine RN, Wilson WA, Donnell GN. Retinal changes in glycogen storage disease type I. Am J Dis Child 1968; 115: 328–331.PubMedGoogle Scholar
  288. 288.
    Schulman JL, Saturen P. Glycogen storage disease of the liver. 1. Clinical studies during the early neonatal period. Pediatrics 1954; 14: 632–643.PubMedGoogle Scholar
  289. 289.
    Fernandes J, Pikaar NA. Ketosis in hepatic glycogenosis. Arch Dis Child 1972; 47: 41–46.PubMedCrossRefGoogle Scholar
  290. 290.
    Nilsson IM, Ockerman PA. Bleeding disorder in hepatomegalic forms of glycogen storage disease. Acta Paediatr Scand 1970; 59: 127–133.PubMedCrossRefGoogle Scholar
  291. 291.
    Zeller WP, Cornblath M, Schwartz HC, Schwartz R. Minor hemoglobins in disorders of carbohydrate metabolism. J Pediatr 1981; 98: 936–938.PubMedCrossRefGoogle Scholar
  292. 292.
    Brante G, Kaijser K, Ockerman PA. Glycogenosis type I (lack of glucose-6-phosphatase) in four siblings. Acta Paediatr Scand 1964;(suppl)157:1–28.CrossRefGoogle Scholar
  293. 293.
    Howell R, Ashton DM, Wyngaarden JB. Glucose-6phosphatase deficiency glycogen storage disease. Studies on the interrelationships of carbohydrate, lipid and purine abnormalities. Pediatrics 1962; 29: 553–565.PubMedGoogle Scholar
  294. 294.
    Folkman J, Philippart A, Tze WJ, Crigler J JR. Portocaval shunt for glycogen storage disease: value of prolonged intravenous hyperalimentation before surgery. Surgery 1972; 72: 306–314.PubMedGoogle Scholar
  295. 295.
    Sidbury JB, Cornblath M, Fisher J, House E. Glycogen in erythrocytes of patient with glycogen storage disease. Pediatrics 1961; 27: 103–111.Google Scholar
  296. 296.
    Williams HE, Field JB. Further studies on leukocyte phosphorylase in glycogen storage disease. Metabolism 1963; 12: 464–466.PubMedGoogle Scholar
  297. 297.
    Williams HE, Kendig EM, Field JB. Leukocyte debranching enzyme in glycogen storage disease. J Clin Invest 1963; 42: 656–660.PubMedCrossRefGoogle Scholar
  298. 298.
    Sokal JE, Lowe CU, Sarcione EJ, et al. Studies of glycogen metabolism in liver glycogen disease (von Gierke’sdisease): six cases with similar metabolic abnormalities and responses to glucagon. J Clin Invest 1961; 40: 364–374.PubMedCrossRefGoogle Scholar
  299. 299.
    Perkoff GT, Parker VJ, Hahn RF. The effects of glucagon in three forms of glycogen storage disease. J Clin Invest 1962; 41: 1099–1105.PubMedCrossRefGoogle Scholar
  300. 300.
    Schwartz R, Ashmore J, Renold AE. Galactose tolerance in glycogen storage disease. Pediatrics 1957; 19: 585–595.PubMedGoogle Scholar
  301. 301.
    Illingworth B. Glycogen storage disease. Am J Clin Nutr 1961; 9: 683–690.Google Scholar
  302. 302.
    Tada K, Narisawa K, Igarashi Y, Kato S. Glycogen storage disease type IB: a new model of genetic disorders involving the transport system of intracellular membrane. Biochem Med 1985; 33: 215–222.PubMedCrossRefGoogle Scholar
  303. 303.
    Villee CA. The intermediary metabolism of human fetal tissues. Cold Spring Harb Symp Quant Biol 1954; 19: 186199.Google Scholar
  304. 304.
    Kalhan SC, Gilfillan C, Tserng K-Y, Savin SM. Glucose production in type I glycogen storage disease. J Pediatr 1982; 101: 159–160.PubMedGoogle Scholar
  305. 305.
    Tsalikian E, Simmons P, Gerich JE, et al. Glucose production and utilization in children with glycogen storage disease type I. Am J Physiol 1984; 247: E513–E519.PubMedGoogle Scholar
  306. 306.
    Mason HH, Sly GE. Blood lactic acid in liver glycogen disease. Proc Soc Exp Biol 1943; 53: 145–147.Google Scholar
  307. 307.
    Oberhaensli RD, Rajagopalan B, Taylor DJ, et al. Study of liver metabolism in glucose-6-phosphatase deficiency (glycogen storage disease type 1A) by P-31 magnetic resonance spectroscopy. Pediatr Res 1988; 23: 375–380.PubMedCrossRefGoogle Scholar
  308. 308.
    Fine RN, Strauss J, Donnell GN. Hyperuricemia in glycogen-storage disease type I. Am J Dis Child 1966; 112: 57 2576.Google Scholar
  309. 309.
    Roe TF, Kogut MD. The pathogenesis of hyperuricemia in glycogen storage disease, type I. Pediatr Res 1977; 11: 664–669.PubMedCrossRefGoogle Scholar
  310. 310.
    Fernandes J, Berger R, Smith GPA. Lactate as a cerebral metabolic fuel for glucose-6-phosphatase deficient children. Pediatr Res 1984; 18: 335–339.PubMedCrossRefGoogle Scholar
  311. 311.
    Leonard JW, Dunger DB. Hypoglycaemia complicating feeding regimens for glycogen storage disease. Lancet 1978; 2: 1203–1204.PubMedCrossRefGoogle Scholar
  312. 312.
    Fine RN, Kogut MD, Donnell GN. Intestinal absorption in type I glycogen storage disease. J Pediatr 1969; 75: 63 2635.Google Scholar
  313. 313.
    Moses SW, Gutman A. Inborn errors of glycogen metabolism. Adv Pediatr 1972; 19: 95–169.Google Scholar
  314. 314.
    Resnick MB, Kozakewich HPW, Perez-Atayde AR. Hepatic adenoma in the pediatric age group. Am J Surg Pathol 1995; 19 (10): 1181–1190.PubMedCrossRefGoogle Scholar
  315. 315.
    Roe T, Kogut M, Buckingham B, et al. Hepatic tumors in glycogen storage disease type 1. Clin Res 1978; 26: 191A.Google Scholar
  316. 316.
    Grossman H, Ram PC, Coleman RA, et al. Hepatic ultrasonography in type I glycogen storage disease (von Gierke disease). Radiology 1981; 141: 753–756.PubMedGoogle Scholar
  317. 317.
    Brunelle F, Tammam S, Odierre M, Chaumont P. Liver adenomas in glycogen storage disease in children. Pediatr Radiol 1984; 14: 94–101.PubMedCrossRefGoogle Scholar
  318. 318.
    Chen YT, Coleman RA, Scheinman JI, et al. Renal disease in type 1 glycogen storage disease. N Engl J Med 1988; 381: 7–11.CrossRefGoogle Scholar
  319. 319.
    Restaino I, Stanley C, Baker L, et al. Renal tubular abnormalities and nephrocalcinosis in patients with type la glycogen storage disease. Pediatr Res 1990; 27 (4): 337A.CrossRefGoogle Scholar
  320. 320.
    Greene HL, Slonim AE, O’Neill JA Jr, Burr IM. Continuous nocturnal intragastric feeding for management of type 1 glycogen storage disease. N Engl J Med 1976; 294: 423–425.PubMedCrossRefGoogle Scholar
  321. 321.
    Stanley CA, Mills JL, Baker L. Intragastric feeding in type I glycogen storage disease: factors affecting the control of lactic acidemia. Pediatr Res 1981; 15: 1504–1508.PubMedCrossRefGoogle Scholar
  322. 322.
    Chen Y-T, Cornblath M, Sidbury JB. Cornstarch therapy in type I glycogen storage disease. N Engl J Med 1984; 310: 171–175.PubMedCrossRefGoogle Scholar
  323. 323.
    Fernandes J, Leonard JV, Moses SW, et al. Glycogen storage disease: recommendations for treatment. Eur J Pediatr 1988; 147: 226–228.PubMedCrossRefGoogle Scholar
  324. 324.
    Kalhan S, Rossi K. Glucose kinetics in type I and type III glycogen storage disease. In: Chapman TE, Berger R, Reijngoud DJ, eds. Stable isotopes in pediatrics nutritional and metabolic research. London: Intercept, 1990: 237–247.Google Scholar
  325. 325.
    Starzl TE, Putnam CW, Porter KA, et al. Portal diversion for the treatment of glycogen storage disease in humans. Ann Surg 1973; 178: 525–539.PubMedCrossRefGoogle Scholar
  326. 326.
    Johnson MP, Compton A, Drugan A, Evans MI. Metabolic control of von Gierke disease (glycogen storage disease type Ia) in pregnancy: maintenance of euglycemia with cornstarch. Obstet Gynecol 1990; 75: 507–510.PubMedGoogle Scholar
  327. 327.
    Lei K-J, Shelly LL, Pan C-J, et al. Mutations in the glucose-6-phosphatase genes that cause glycogen storage disease type la. Science 1993; 262: 580–583.PubMedCrossRefGoogle Scholar
  328. 328.
    Lei K-J, Pan C-J, Shelly LL, et al. Identification of mutations in the gene for glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type la. J Clin Invest 1994; 93: 1994–1999.PubMedCrossRefGoogle Scholar
  329. 329.
    Lei K-J, Shelly LL, Lin B, et al. Mutations in the glucose6-phosphatase gene are associated with glycogen storage disease type la and 1aSP, but not lb and lc. J Clin Invest 1995; 95: 234–240.PubMedCrossRefGoogle Scholar
  330. 330.
    Lei K-J, Pan C-J, Liu J-L, et al. Structure-function analysis of human glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type la. J Biol Chem 1995; 270 (20): 11882–11886.PubMedCrossRefGoogle Scholar
  331. 331.
    Lei K-J, Chen Y-T, Chen H, et al. Genetic basis of glycogen storage disease type la: prevalent mutations at the glucose-6-phosphatase locus. Am J Hum Genet 1995; 57: 766–771.PubMedGoogle Scholar
  332. 332.
    Kajihara S, Matsuhashi S, Yamamoto K, et al. Exon redefinition by a point mutation within exon 5 of the glucose-6-phosphatase gene is the major cause of glycogen storage disease type la in Japan. Am J Hum Genet 1995; 57: 549–555.PubMedGoogle Scholar
  333. 333.
    Parvari L, Moses S, Hershkovitz E, et al. Characterization of the mutations in the glucose-6-phosphatase gene in Israeli patients with glycogen storage disease type la: R83C in six Jews and a novai V166G mutation in a Muslim Arab.J Inherited Metab Dis 1995; 18: 21–27.PubMedCrossRefGoogle Scholar
  334. 334.
    Field JB, Epstein S, Egan T. Studies in glycogen storage disease. I. Intestinal glucose-6-phosphatase activity in pa-tients with von Gierke’s disease and their parents. J Clin Invest 1965; 44: 1240–1247.PubMedCrossRefGoogle Scholar
  335. 335.
    Senior B, Loridan L. Studies of liver glycogenoses, with particular reference to the metabolism of intravenously administered glycerol. N Engl J Med 1968; 279: 958–964.PubMedCrossRefGoogle Scholar
  336. 336.
    Narisawa K, Igarashi Y, Otomo H, et al. A new variant of glycogen storage disease type 1 probably due to a defect in the glucose-6-phosphate transport system. Biochem Biophys Res Commun 1978; 83: 1360–1364.PubMedCrossRefGoogle Scholar
  337. 337.
    Nordlie RC, Sukalski KA, Munoz JM, et al. Type lc, a novel glycogenosis: underlying mechanisms. J Biol Chem 1983; 258: 9739–9744.PubMedGoogle Scholar
  338. 338.
    Shin YS, Rieth M, Tansendfreund J, Endres W. A sensitive radioisotopic method for glucose-6-phosphatase assay and diagnosis of glycogenosis type lb using polymorphonuclear leukocytes. Personal communication.Google Scholar
  339. 339.
    Bashan N, Potashnik R, Hagai Y, Moses SW. Impaired glucose transport in polymorphonuclear leukocytes in glycogen storage disease Ib. J Inherited Metab Dis 1987; 10: 234–241.PubMedCrossRefGoogle Scholar
  340. 340.
    Bashan N, Hagai Y, Potashnik R, Moses SW. Impaired carbohydrate metabolism of polymorphonuclear leukocytes in glycogen storage disease Ib. J Clin Invest 1988; 81: 1317–1322.PubMedCrossRefGoogle Scholar
  341. 341.
    Seger R, Steinmann B, Tiefenauer L, et al. Glycogenosis Ib: neutrophil microbicidal defects due to impaired hexose monophosphate shunt. Pediatr Res 1984; 18: 297–299.PubMedCrossRefGoogle Scholar
  342. 342.
    Koven ML, Clark MM, Cody CS, et al. Impaired chemotaxis and neutrophil (polymorphonuclear leukocyte) function in glycogenosis type IB. Pediatr Res 1986; 20: 438–442.PubMedCrossRefGoogle Scholar
  343. 343.
    Illingworth B, Cori GT. Structure of glycogens and amylopectins. III. Normal and abnormal human glycogen. J Biol Chem 1952; 199: 653–660.PubMedGoogle Scholar
  344. 344.
    Forbes GB. Glycogen storage disease. J Pediatr 1953; 42: 645–653.PubMedCrossRefGoogle Scholar
  345. 345.
    Van Creveld S, Huijing F. Differential diagnosis of the type of glycogen disease in two adult patients with long history of glycogenosis. Metabolism 1964; 13: 191–194.CrossRefGoogle Scholar
  346. 346.
    Hug G, Krill CE Jr, Perrin EV, Guest GM. Cori’s disease (amylo-1,6-glucosidase deficiency). N Engl J Med 1963; 268: 113–120.PubMedCrossRefGoogle Scholar
  347. 347.
    Fernandes J, Koster JF, Grose WF, Sorgedrager N. Hepatic phosphorylase deficiency. Its differentiation from other hepatic glycogenoses. Arch Dis Child 1974; 49: 186–191.PubMedCrossRefGoogle Scholar
  348. 348.
    Moses SW, Chayoth R, Levin S, et al. Glucose and glycogen metabolism in erythrocytes from normal and glycogen storage disease type III subjects. J Clin Invest 1968; 47: 1343–1348.PubMedCrossRefGoogle Scholar
  349. 349.
    Huijing F. Enzymes of glycogen metabolism in leukocytes in relation to glycogen-storage disease. In: Whelan WJ, ed. Control of glycogen metabolism. Oslo: Oslo University Press (Universitetsforlaget), 1968: 115–128.Google Scholar
  350. 350.
    Illingworth B, Cori GT, Cori CF. Amylo-1,6-glucosidase in muscle tissue in generalized glycogen storage disease. J Biol Chem 1956; 218: 123–129.PubMedGoogle Scholar
  351. 351.
    Ding SH,, de Barsy T, Brown BI et al. Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III. J Pediatr 1990; 116: 95–100.PubMedCrossRefGoogle Scholar
  352. 352.
    Neustein HB. Fine structure of skeletal muscle in type III glycogenosis. Arch Pathol 1969; 88: 130–136.PubMedGoogle Scholar
  353. 353.
    Powell HC, Haas R, Hall CL, et al. Peripheral nerve in type III glycogenosis: selective involvement of unmyelinated fiber Schwann cells. Muscle Nerve 1985; 8: 667–671.PubMedCrossRefGoogle Scholar
  354. 354.
    Garty BZ, Dinari G, Nitzan M. Transient acute cortical blindness associated with hypoglycemia. Pediatr Neurol 1987; 3: 169–170.PubMedCrossRefGoogle Scholar
  355. 355.
    Moses SW, Gadoth N, Bashan N, et al. Neuromuscular involvement in glycogen storage disease type III. Acta Paediatr Scand 1986; 75: 289–296.PubMedCrossRefGoogle Scholar
  356. 356.
    Moses SW, Wanderman KL, Myroz A, Frydman M. Cardiac involvement in glycogen storage disease type III. Eur J Pediatr 1989; 148: 764–766.PubMedCrossRefGoogle Scholar
  357. 357.
    Bridge EM, Holt LE Jr. Glycogen storage disease; observations on the pathologic physiology of two cases of the hepatic form of the disease. J Pediatr 1945; 27: 299–315.CrossRefGoogle Scholar
  358. 358.
    Fernandes J, Vande Kamer JH. Hexose and protein tolerance tests in children with liver glycogenosis caused by a deficiency of the debranching enzyme system. Pediatrics 1968; 41: 935–944.PubMedGoogle Scholar
  359. 359.
    Levin S, Moses SW, Chayoth R, et al. Glycogen storage disease in Israel. Isr J Med Sci 1967; 3: 397–410.PubMedGoogle Scholar
  360. 360.
    Van Creveld S, Huijing F. Glycogen storage disease. Biochemical and clinical data in sixteen cases. Am J Med 1965; 38: 554–561.CrossRefGoogle Scholar
  361. 361.
    Huijing F, Obbink HJK, Van Creveld S. Activity of the debranching enzyme system in leukocytes. Acta Genet (Basel) 1968; 18: 128–136.Google Scholar
  362. 362.
    Milunsky A, Littlefield JW, Kanfer JN, et al. Prenatal genetic diagnosis. N Engl J Med 1970; 283: 1370–1381.PubMedCrossRefGoogle Scholar
  363. 363.
    Ding JH, Harris DA, Bing-Zi Y, Chen YT. Cloning of cDNA for human muscle glycogen debrancher, the enzyme deficient in type III glycogen storage disease. Pediatr Res 1989; 25: 140A.Google Scholar
  364. 364.
    Hers HG, Van-Hoof F, DeBarsey T. The glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolism basis of inherited disease. 6th ed. New York: McGraw-Hill, 1989: 425–452.Google Scholar
  365. 365.
    Yang BZ, Ding HG, Enghild JJ, et al. Molecular cloning and nucleotide sequence of cDNA encoding human muscle glycogen debranching enzyme. J Biol Chem 1992; 267: 9294–9299.PubMedGoogle Scholar
  366. 366.
    Yang BZ, Ding HG, Bao Y, et al. Molecular basis of the enzymatic variability in type III glycogen storage disease (GSD III). Am J Hum Genet 1992; 51 (Suppl): A28.Google Scholar
  367. 367.
    Bao Y, Yang BZ, Chen YT. Structural organization of the multifunctional human glycogen debrancher gene. Am J Hum Genet 1993; 53: 662A.Google Scholar
  368. 368.
    Yang-Feng TL, Zheng K, Yu J, et al. Assignment of the human glycogen debrancher gene to chromosome 1p21. Genomics 1992; 13: 931–934.PubMedCrossRefGoogle Scholar
  369. 369.
    Mishori-Dery A, Bashan N, Moses S, et al. RFLPs for linkage analysis in families with glycogen storage disease type III. J Inherited Metab Dis 1995; 18: 207–210.PubMedCrossRefGoogle Scholar
  370. 370.
    Hers HG. Etudes enzymatiques sur fragments hépatiques; application a la classification des glycogenosés. Rev Int Hepatol 1959; 9: 35–55.PubMedGoogle Scholar
  371. 371.
    Lamy M, Dubois R, Rossier A, et al. La glycogenose par defici. Arch Fr Pediatr 1960; 17: 14–37.PubMedGoogle Scholar
  372. 372.
    Hulsmann WC, Oei TL, Van Creveld S. Phosphorylase activity in leukocytes from patients with glycogen storage disease. Lancet 1961; 2: 581–583.PubMedCrossRefGoogle Scholar
  373. 373.
    Williams HE, Field JB. Low leukocyte phosphorylase in hepatic phosphorylase deficient glycogen storage disease. J Clin Invest 1961; 40: 1841–1845.PubMedCrossRefGoogle Scholar
  374. 374.
    Willems PJ, Gerver WJ, Berger R, Fernandes J. The natural history of liver glycogenesis due to phosphorylase kinase deficiency: a longitudinal study of 41 patients. Eur J Pediatr 1990; 149: 268–271.PubMedCrossRefGoogle Scholar
  375. 375.
    Christiansen RO, Page LA, Greenberg RE. Glycogen storage in a hepatoma: dephosphorylase kinase defect. Pediatrics 1968; 42: 694–696.PubMedGoogle Scholar
  376. 376.
    Hug G, Garancis JC, Schubert WK, Kaplan S. Glycogen storage disease, type II, III, VII and IX. Am J Dis Child 1966; 111: 457–474.Google Scholar
  377. 377.
    Hug G, Schubert WK, Chuck G. Deficient activity of dephosphorylase kinase and accumulation of glycogen in the liver. J Clin Invest 1969; 48: 704–715.PubMedCrossRefGoogle Scholar
  378. 378.
    Huijing F, Fernandes J. X-Chromosomal inheritance of liver glycogenosis with phosphorylase kinase deficiency. Am J Hum Genet 1969; 21: 275–284.PubMedGoogle Scholar
  379. 379.
    Baussan C, Moatti N, Odievre M, Lemonnier A. Liver glycogenosis caused by a defective phosphorylase system. Hemolysate analysis. Pediatrics 1981; 67: 107–112.PubMedGoogle Scholar
  380. 380.
    Shin YS, Rieth M, Tausenfreund J, et al. Clinical and biochemical variability of phosphorylase B, kinase deficiency: its differentiation using erythrocyte parameters. Personal communication.Google Scholar
  381. 381.
    Tuchman M, Brown BI, Burke BA, Ulstrom RA. Clinical and laboratory observations in a child with hepatic phosphorylase kinase deficiency. Metabolism 1986; 35: 627633.Google Scholar
  382. 382.
    Lederer B, Van Hoof F, Vanden Berghe G, Hers HG. Glycogen phosphorylase and its converter enzymes in haemolysates of normal human subjects and of patients with type VI glycogen storage disease. A study of phosphorylase kinase deficiency. Biochem J 1975; 147: 23–35.PubMedGoogle Scholar
  383. 383.
    Newgard CB, Fletterick RJ, Anderson LA, Lebo RV. The polymorphic locus for glycogen storage disease VI (liver glycogen phosphorylase) maps to chromosome 14. Am J Hum Genet 1987; 40: 351–364.PubMedGoogle Scholar
  384. 384.
    Francke U, Darras BT, Zander NF, Kiliman MW. Assignment of human genes for phosphorylase kinase subunits alpha (PHKA) to Xq12-q13 and beta (PHKB) to 16g12-q13. Am J Hum Genet 1989; 45: 276–282.PubMedGoogle Scholar
  385. 385.
    Lamer J, Villar-Palasi C. Enzymes in glycogen storage myopathy. Proc Natl Acad Sci USA 1959; 45: 1234–1235.CrossRefGoogle Scholar
  386. 386.
    Schmid R, Robbins PW, Traut RR. Glycogen synthesis in human muscle lacking phosphorylase. Proc Natl Acad Sci USA 1959; 45: 1236–1240.PubMedCrossRefGoogle Scholar
  387. 387.
    Schmid R, Mahler R. Chronic progressive myopathy with myoglobinuria; demonstration of a glycogenolytic defect in the muscle. J Clin Invest 1959; 38: 2044–2058.PubMedCrossRefGoogle Scholar
  388. 388.
    Pearson CM, Rimer DG, Mommaerts WFHM. A metabolic myopathy due to absence of muscle phosphorylase. Am J Med 1961; 30: 502–517.PubMedCrossRefGoogle Scholar
  389. 389.
    Andres R, Cader G, Zierler KL. The quantitatively minor role of carbohydrate in oxidative metabolism by skeletal muscle in intact man in the basal state. Measurements of oxygen and glucose uptake and carbon dioxide and lactate production in the forearm. J Clin Invest 1956; 35: 671–682.PubMedCrossRefGoogle Scholar
  390. 390.
    Mahler RF, McArdle B. Specific enzyme defect in glycogen breakdown causing a myopathy. Q J Med 1960; 29: 638 (Abstract).Google Scholar
  391. 391.
    Schmid R, Hammaker L. Hereditary absence of muscle phosphorylase (McArdle’s syndrome). N Engl J Med 1961; 264: 223–225.PubMedCrossRefGoogle Scholar
  392. 392.
    Lebo RV, Gorin F, Fletterick RJ, et al. High resolution chromosome sorting and DNA spot-blot analysis assign McArdle’s syndrome to chromosome 11. Science 1984; 225: 57–59.PubMedCrossRefGoogle Scholar
  393. 393.
    Tarui S, Okuno G, Ikara Y, et al. Phosphofructokinase deficiency in skeletal muscle. A new type of glycogenosis. Biochem Biophys Res Commun 1965; 19: 517–523.PubMedCrossRefGoogle Scholar
  394. 394.
    Okuno G, Hizukuri S, Nishikawa M. Activities of glycogen synthetase and UDPGA-pyrophosphorylase in muscle of a patient with a new type of muscle glycogenosis caused by phosphofructokinase deficiency. Nature (Lond) 1966; 212: 1490–1491.CrossRefGoogle Scholar
  395. 395.
    Tarui S, Koni N, Nasu T, Nishikawa M. Enzymatic basis for the co-existence of myopathy and hemolytic disease inherited muscle phosphofructokinase deficiency. Biochem Biophys Res Commun 1969; 34: 77–83.PubMedCrossRefGoogle Scholar
  396. 396.
    Layzer RB, Rowland LP, Ranney HM. Muscle phosphofructokinase deficiency. Arch Neurol 1967; 17: 512–523.PubMedCrossRefGoogle Scholar
  397. 397.
    DiSant’Agnese PA, Andersen DH, Mason HH, Bauman WA. Glycogen storage disease of the heart. I. Report of two cases in siblings with chemical and pathologic studies. Pediatrics 1950; 6: 402–424.Google Scholar
  398. 398.
    Brown BI, Zellweger H. a-1,4-glucosidase activity in leucocytes from the family of two brothers who lack this enzyme in muscle. Biochem J 1966; 101: 16C.Google Scholar
  399. 399.
    Nihill MR, Wilson DS, Hugh-Jones R. Generalized glycogenosis type II (Pompe’s disease). Arch Dis Child 1070; 45: 122–129.CrossRefGoogle Scholar
  400. 400.
    Dincsoy MY, Dincsoy HP, Kessler AD, et al. Generalized glycogenosis and associated endocardial fibroelastosis. J Pediatr 1965; 67: 728–740.PubMedCrossRefGoogle Scholar
  401. 401.
    Clement DH, Godman GC. Glycogen disease resembling mongolism, cretinism and amyotonia congenita. J Pediatr 1950; 36: 11–30.PubMedCrossRefGoogle Scholar
  402. 402.
    Kahana D, Telem C, Steinitz K, Solomon M. Generalized glycogenosis. J Pediatr 1964; 65: 243–251.PubMedCrossRefGoogle Scholar
  403. 403.
    deBarsy T, Ferriere G, Fernandez-Alvarez E. Uncommon case of type II glycogenosis. Acta Neuropathol 1979; 47: 245–247.CrossRefGoogle Scholar
  404. 404.
    Huijing F, Van Creveld S, Losekoot G. Diagnosis of generalized glycogen storage disease (Pompe’s disease). J Pediatr 1963; 63: 984–987.PubMedCrossRefGoogle Scholar
  405. 405.
    Lejeune N, Thines-Sempoux D, Hers HG. Tissue fractionation studies. 16. Intracellular distribution and properties of a-glucosidases in rat liver. Biochem J 1963; 86: 16–21.PubMedGoogle Scholar
  406. 406.
    Dancis J, Hutzler L, Lynfield L, Cox RP. Absence of acid maltase in glycogenosis type 2 (Pompe’s disease) in tissue culture. Am J Dis Child 1969; 117: 108–111.PubMedGoogle Scholar
  407. 407.
    Nitowsky HM, Gounefeld A. Lysosomal a-glucosidases in type II glycogenosis. J Lab Clin Med 1967; 69: 472–484.PubMedGoogle Scholar
  408. 408.
    Nadler HG, Messina AM. In utero detection of type II glycogenosis ( Pompe’s disease ). Lancet 1969; 2: 1277–1278.Google Scholar
  409. 409.
    Cox RP, Douglas G, Hutzler J, et al. In utero detection of Pompe’s disease. Lancet 1970; 1: 893.PubMedCrossRefGoogle Scholar
  410. 410.
    Shin YS, Rieth M, Tausenfreund J, Endres W. First trimester diagnosis of glycogenosis type II and type III. J Inherited Metab Dis 1989; 12 (suppl 2): 289–291.PubMedCrossRefGoogle Scholar
  411. 411.
    Bashan N, Potashnik R, Barash V, et al. Glycogen storage disease type II in Israel. Isr J Med Sci 1988; 24: 224–227.PubMedGoogle Scholar
  412. 412.
    Reuser AJJ, Koster JF, Hoogeveen A, et al. Biochemical, immunological and cell genetic studies in glycogenosis type II. Am J Hum Genet 1978; 30: 132–143.PubMedGoogle Scholar
  413. 413.
    D’Ancona GG, Wurm J, Croce CM. Genetics of type II glycogenosis: assignment of the human gene for acid alpha-glucosidase to chromosome 17. Proc Natl Acad Sci USA 1977; 76: 4526–4529.CrossRefGoogle Scholar
  414. 414.
    Kleijer WJ, Vander Kraan M, Kroos MA, et al. Prenatal diagnosis of glycogen storage disease type II; enzyme assay or mutation analysis? Pediatr Res 1995; 38: 103–106.PubMedCrossRefGoogle Scholar
  415. 415.
    Niermeijer MF, Kostar JF, Jahodova M, et al. Prenatal diagnosis of type II glycogenosis (Pompe’s disease) using microchemical analyses. Pediatr Res 1975; 9: 498–503.PubMedCrossRefGoogle Scholar
  416. 416.
    Besancon A-M, Gastelnau L, Nicolesco H, et al. Prenatal diagnosis of glycogenesis type II (Pompe’s disease) using chorionic villi biopsy. Clin Genet 1985; 27: 479–482.PubMedCrossRefGoogle Scholar
  417. 417.
    Grubisic A, Shin YS, Meyer W, et al. First trimester diagnoses of Pompe’s disease (glycogenosis type II) with normal outcome: assay of acid a-glucosidase in chorionic villus biopsy using antibodies. Clin Genet 1986; 30: 298–301.PubMedCrossRefGoogle Scholar
  418. 418.
    Reuser AJJ, Kroos MA, Hermans MMP, et al. Glycogenosis type II (acid maltase deficiency). Muscle Nerve 1995; 18 (suppl 3): S61–S69.CrossRefGoogle Scholar
  419. 419.
    Brown BI, Brown DH. Lack of an a-1,4 glucan: a-1,4glucan 6 glycosyl transferase in a case of type IV glycogenosis. Proc Natl Acad Sci USA 1966; 56: 725–729.PubMedCrossRefGoogle Scholar
  420. 420.
    Shin YS, Steiguber H, Klemm P, et al. Branching enzyme in erythrocytes. Detection of type IV glycogenosis homozygotes and heterozygotes. J Inherited Metab Dis 1988; 11 (2): 252–254.PubMedCrossRefGoogle Scholar
  421. 421.
    Fernandes J, Huijing F. Branching enzyme-deficiency glycogenosis: studies in therapy. Arch Dis Child 1968; 43: 347–352.PubMedCrossRefGoogle Scholar
  422. 422.
    Levin B, Burgess EA, Mortimer PE. Glycogen storage disease type IV, amylopectinosis. Arch Dis Child 1968; 43: 548–555.PubMedCrossRefGoogle Scholar
  423. 423.
    Sidbury JB Jr, Mason J, Burns WB Jr, Reubner BH. Type IV glycogenosis. Report of a case proven by characterization of glycogen and studied at necropsy. Bull Johns Hopkins Hosp 1962; 111: 157–181.PubMedGoogle Scholar
  424. 424.
    Reed DB JR, Dixon LFP, Neustein HB, et al. Type IV glycogenosis. Lab Invest 1968; 19: 546–557.PubMedGoogle Scholar
  425. 425.
    Starzl TE, Zifelli BJ, Shaw BW, et al. Changing concepts of liver replacement for hereditary tyrosinemia and hepatoma. J Pediatr 1985; 106: 604–606.PubMedCrossRefGoogle Scholar
  426. 426.
    Kleinman RE, Vacanti JP. Liver transplantation. In: Walker WA, Durie P, Hamilton JE, et al., eds. Pediatric gastrointestinal disease: pathophysiology, diagnosis and management. Ontario: BC Decker, 1991: 1108–1124.Google Scholar
  427. 427.
    Aynsley-Green A, Williamson DH, Gitzelmann R. Hepatic glycogen synthetase deficiency. Definition of syndrome from metabolic and enzyme studies on a 9-year-old girl. Arch Dis Child 1977; 52: 573–579.PubMedCrossRefGoogle Scholar
  428. 428.
    Parr J, Teree TM, Lamer J. Symptomatic hypoglycemia, visceral fatty metamorphosis and aglycogenosis in an infant lacking glycogen synthetase and phosphorylase. Pediatrics 1965; 35: 770–777.PubMedGoogle Scholar
  429. 429.
    Cornblath M, Steiner DF, Bryan P, King J. Uridinediphosphoglucose glucosyl glucosyltransferase in human erythrocytes. Clin Chim Acta 1965; 12: 27–32.PubMedCrossRefGoogle Scholar
  430. 430.
    Spencer-Peet J. Erythrocyte glycogen synthetase in glycogen storage deficiency resulting from the absence of this enzyme from liver. Clin Chim Acta 1964; 10: 481–483.PubMedCrossRefGoogle Scholar
  431. 431.
    Gitzelmann R, Steinmann B, Aynsley-Green A. Hepatic glycogen synthetase deficiency not expressed in cultured skin fibroblasts. Clin Chim Acta 1983; 130: 111–115.PubMedCrossRefGoogle Scholar
  432. 432.
    Gitzelmann R, Aynsley-Green A, Williamson DH. Blood cell glycogen synthetase activity in hepatic glycogen synthetase deficiency. Clin Chim Acta 1977; 79: 219–221.PubMedCrossRefGoogle Scholar
  433. 433.
    Aynsley-Green A, Williamson DH, Gitzelmann R. The dietary treatment of hepatic glycogen synthetase deficiency. Helv Paediatr Acta 1977; 32: 71–75.PubMedGoogle Scholar
  434. 434.
    Dykes JRW, Spencer-Peet J. Hepatic glycogen synthetase deficiency. Further studies on a family. Arch Dis Child 1972; 47: 558–563.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Robert Schwartz

There are no affiliations available

Personalised recommendations